v3.26.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 9 Months Ended
Jul. 03, 2026
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:
July 3, 2026July 4, 2025
(In millions)Beginning of PeriodEnd of PeriodBeginning of PeriodEnd of Period
Cash and cash equivalents$145.0 $99.2 $168.7 $136.4 
Restricted cash2.1 1.9 1.7 2.1 
Total as presented in the Condensed Consolidated Statements of Cash Flows$147.1 $101.1 $170.4 $138.5 
Schedule of Restrictions on Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:
July 3, 2026July 4, 2025
(In millions)Beginning of PeriodEnd of PeriodBeginning of PeriodEnd of Period
Cash and cash equivalents$145.0 $99.2 $168.7 $136.4 
Restricted cash2.1 1.9 1.7 2.1 
Total as presented in the Condensed Consolidated Statements of Cash Flows$147.1 $101.1 $170.4 $138.5 
Schedule of Customers with a Significant Portion of Revenue During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:
Three Months EndedNine Months Ended
July 3, 2026July 4, 2025July 3, 2026July 4, 2025
Canon Medical Systems Corporation15.3 %17.8 %16.8%17.8%
Schedule of Product Warranty Liability The following table reflects the changes in the Company’s accrued product warranty:
Nine Months Ended
(In millions)July 3, 2026July 4, 2025
Accrued product warranty, at beginning of period$8.5 $10.8 
New accruals charged to cost of revenues12.7 10.0 
Product warranty expenditures(12.1)(11.6)
Accrued product warranty, at end of period$9.1 $9.2